Classification of Antiarrhythmic Drugs
- 1 May 1989
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 29 (5), 387-394
- https://doi.org/10.1002/j.1552-4604.1989.tb03350.x
Abstract
Although many classification schemes for antiarrhythmic drugs have been proposed, the system introduced by Vaughan Williams and later modified by Harrison has been widely accepted. This classification system is comprised of four categories. Class I agents block sodium channels. Class II agents are Beta blockers. Class III agents prolong the cardiac action potential. Class IV agents are calcium channel blockers. This classification scheme, based largely on clinical observation continues to be useful almost two decades after its introduction. The electrophysiologic bases, strengths and weaknesses of this system are discussed.This publication has 31 references indexed in Scilit:
- Sotalol for refractory sustained ventricular tachycardia and nonfatal cardiac arrestThe American Journal of Cardiology, 1988
- Long-term experience with sotalol in the treatment of complex ventricular arrhythmiasAmerican Heart Journal, 1987
- Antiarrhythmic drug classification: New science and practical applicationsThe American Journal of Cardiology, 1985
- Beta-adrenoceptor blockade: Electrophysiology and antiarrhythmic mechanismsAmerican Heart Journal, 1984
- Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic propertiesAmerican Heart Journal, 1984
- A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsThe Journal of Clinical Pharmacology, 1984
- Ventricular Antiarrhythmic Effects of Beta‐Adrenergic Blocking Drugs: A Review of Mechanism and Clinical StudiesThe Journal of Clinical Pharmacology, 1982
- The long QT syndrome: Effects of drugs and left stellate ganglion blockAmerican Heart Journal, 1982
- Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmiasAmerican Heart Journal, 1981
- Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodaroneAmerican Heart Journal, 1981